Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918343 | Radiotherapy and Oncology | 2015 | 6 Pages |
Abstract
Neoadjuvant chemoradiotherapy followed by Ivor-Lewis esophagectomy yields excellent in-field control, as only a clear minority (7.8%) of patients developed a relapse in the RTV. In-field recurrence is associated with widespread tumor dissemination and poor pathological response to neoadjuvant treatment.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Hendrik Thoen, Wim Ceelen, Tom Boterberg, Elke Van Daele, Piet Pattyn,